コンパニオンアニマル(ペット)用薬の世界市場:産業分析・機会分析

◆英語タイトル:Companion Animals Drug Market: Global Industry Analysis and Opportunity Assessment, 2015 – 2025
◆商品コード:FMI609097
◆発行会社(調査会社):Future Market Insights
◆発行日:2015年11月20日
◆ページ数:274
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Individual (single user)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
EnterpriseUSD10,000 ⇒換算¥1,140,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。



※本調査レポートでは、コンパニオンアニマル(ペット)用薬の世界市場について調査・分析し、市場概観、コンパニオンアニマル(ペット)用薬の世界市場規模、市場規模予測、地域別分析(アメリカ、ヨーロッパ、アジア等)、セグメント別市場分析、競争状況、コンパニオンアニマル(ペット)用薬市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

Future Market Insights offers a 10-year forecast of the global companion animal drugs market between 2015 and 2025. In terms of value, the market is expected to register a CAGR of 4.9% during the forecast period. This study demonstrates market dynamics and trends in all seven regions that influence the current environment and future status of the companion animal drugs market over the forecast period.
Report Description

This Future Market Insights report examines the companion animal drugs market for the period 2015–2025. The primary objective of the report is to offer insights into developments in the companion animal drugs market that are significantly transforming global businesses and enterprises.

The companion animal drugs market report begins with defining ‘companion animals’ and the various drug classes used for treating these animals with regard to various ailments. It is followed by an overview of the global companion animal drugs market. The report overview includes FMI analysis of key trends, drivers, restraints, trends and opportunities that are influencing growth of the companion animal drugs market. It also includes an insight into upcoming drug pipeline of various drug makers and market shares of major players, apart from region-specific regulations. Impact analyses of key growth drivers and restraints based on a weighted average model have been included in the companion animal drugs market report to better equip customers and readers with region specific trends and insights.

The primary driving factors for companion animal drugs are rising levels of pet adoption and increasing awareness on animal welfare, including their health and well-being. These have increased demand for pet care services and products including medicines globally. Apart from the above factor, growing market consolidation in the animal healthcare market leads to better focus on companion animal drug making by major drug manufacturers such as Zoetis, Merial and Elanco. The primary factor hampering growth of the companion animal drug market is rising cost for drugs R&D, driven by rising overhead costs and raw material costs.

The global companion animal drugs market is segmented on the basis of product types into antibiotics, anti-inflammatory drugs, parasiticides (further sub-segmented into ecto-parasiticides and endo-parasiticides), heartworm drugs, nutritional, behavioural and skincare drugs and vaccines. A detailed analysis has been provided for every segment and sub-segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.

The report has been segmented based on various drug distribution channels such as veterinary hospitals, veterinary clinics and pharmacies and drug stores, mostly retail in nature. Our analysis predicts that veterinary clinics is the easiest and most preferred channel for drug distribution globally. Ease of establishment, lower cost of infrastructure, availability of veterinarians and wide coverage of drugs are factors promoting increasing number of veterinary clinic set-ups across the world.

The next section of the report highlights companion animal drugs adoption by region. It provides a market outlook for 2015–2025 and sets the forecast within the context of the companion animal drugs market. The study discusses key regional trends contributing to growth of the companion animal drugs market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and Middle East & Africa.

The above sections – by product type, distribution channel and region – evaluate the present scenario and growth prospects of the companion animal drugs market for the period 2015 –2025. We have considered 2014 as the base year and provide data for the forecast period, i.e. 2015–2015.

To ascertain companion animal drugs market size, we have also considered revenue generated by drug manufacturers. The forecast presented here assesses the total revenue by value across the companion animal drugs market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the companion animal drugs market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome of three different types of analysis, based on supply side, downstream industry demand and the economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse based on key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the companion animal drugs market.

The companion animal drugs segments in terms of product, distribution channel and regions are analysed in terms of Basis Point Share (BPS) to understand individual segment’s relative contributions to market growth. This detailed level of information is important for identification of various key trends in the companion animal drugs market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the companion animal drugs market.

To understand key growth segments in terms of growth and adoption for the eight product segments across the globe in the near future, Future Market Insights developed the companion animal drugs market ‘Attractiveness Index’. The resulting index should help providers identify real market opportunities.

In the final section of the report on companion animal drugs, ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, based on categories of providers in the value chain of the companion animal drugs product portfolio and key differentiators. Key categories of providers covered in the report are companion animal drugs manufacturers. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the companion animal drugs value chain and the potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in companion animal drugs marketplace.

Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings, SWOT analysis and recent developments in the companion animal drugs market. Key competitors covered in terms of manufacturers include Zoetis Inc., Elanco (Eli Lilly), Merck Animal Health, Bayer Animal Healthcare, Merial (Sanofi), Boehringer Ingelheim GmbH, Virbac Animal Health and Ceva Santé Animale.

Key Segments Covered

Product Type
Antibiotics
Anti-Inflammatory Drugs
Parasiticides
Heartworm Products
Nutritional Drugs
Behavioural Drugs
Skincare Products
Vaccines
By Distribution Channel
Veterinary Hospitals
Veterinary Clinics
Pharmacies and Drug Stores

Key Regions/Countries Covered

North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Western Europe
U.K.
France
Germany
Spain
Italy
Nordics
BENELUX
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific Excluding Japan (APEJ)
Greater China
India
ASEAN
Australia and New Zealand
Rest of APEJ
Japan
Middle East & Africa
GCC
South Africa
Rest of MEA

Key Companies

Zoetis Inc.,
Elanco (Eli Lilly),
Merck Animal Health,
Bayer Animal Healthcare,
Merial (Sanofi),
Boehringer Ingelheim GmbH,
Virbac Animal Health
Ceva Santé Animale

【レポートの目次】

Table Of Content

1. Executive Summary and Key Insights

2. Research Methodology

3. Market Definition and Taxonomy

4. Market Overview

4.1. Why companion animal adoption trend is growing

4.2. Popular drug classes with examples

4.3. Drivers, Restraints, Opportunities, Trends

4.4. Regulations and PEST Analysis

4.5. M& A Activities

4.6. Drug Pipelines

5. Global Companion Animal Drug Market Forecast 2015-2025

5.1. Introduction

5.1.1. Global Companion Animal Drug Y-o-Y Growth Comparison, By Product Type

5.1.2. Global Companion Animal Drug Market Absolute $ Opportunity, By Product Type

5.1.3. Global Companion Animal Drug BPS Analysis, By Product Type

5.2. Product Type

5.2.1. Antibiotics Segment

5.2.1.1. Y-o-Y Growth Comparison

5.2.1.2. Absolute $ Opportunity

5.2.2. Anti-inflammatory Products Segment

5.2.2.1. Y-o-Y Growth Comparison

5.2.2.2. Absolute $ Opportunity

5.2.3. Parasiticides

5.2.3.1. Y-o-Y Growth Comparison

5.2.3.2. Absolute $ Opportunity

5.2.4. Heartworm

5.2.4.1. Y-o-Y Growth Comparison

5.2.4.2. Absolute $ Opportunity

5.2.5. Behavioral Products

5.2.5.1. Y-o-Y Growth Comparison

5.2.5.2. Absolute $ Opportunity

5.2.6. Nutritional Products

5.2.6.1. Y-o-Y Growth Comparison

5.2.6.2. Absolute $ Opportunity

5.2.7. Skin Care Products

5.2.7.1. Y-o-Y Growth Comparison

5.2.7.2. Absolute $ Opportunity

5.2.8. Vaccines Product

5.2.8.1. Y-o-Y Growth Comparison

5.2.8.2. Absolute $ Opportunity

5.3. Global Companion Animals Drug Market Attractiveness Analysis By Product Type

5.4. Distribution Type

5.4.1. Veterinary Hospitals

5.4.1.1. Y-o-Y Growth Comparison

5.4.1.2. Absolute $ Opportunity

5.4.2. Veterinary Clinics

5.4.2.1. Y-o-Y Growth Comparison

5.4.2.2. Absolute $ Opportunity

5.4.3. Pharmacies and Drug Stores

5.4.3.1. Y-o-Y Growth Comparison

5.4.3.2. Absolute $ Opportunity

5.4.4. Global Companion Animals Drug Market Y-o-Y Growth By Distribution Type

5.4.5. Global Companion Animals Drug Market Value Share By Distribution Type

5.4.6. Global Companion Animals Drug Market Attractiveness Analysis By Distribution Type

5.5. Region

5.5.1. Introduction

5.5.2. Global Companion Animals Drug Market Y-o-Y Growth By Region

5.5.3. Global Companion Animals Drug Market Revenue Proportion By Region

5.5.4. Global Companion Animals Drug Market Attractiveness Analysis By Region

6. North America Companion Animal Drug Market Forecast 2015-2025

6.1. Introduction

6.1.1. Y-o-Y Growth Comparison

6.1.2. Absolute $ Opportunity

6.1.3. Global Companion Animal Drug BPS Analysis, By Region

6.2. North America Companion Animals Drug Market By Country

6.2.1. U.S.

6.2.2. Canada

6.3. Product Type

6.3.1. Antibiotics Segment

6.3.1.1. Y-o-Y Growth Comparison

6.3.1.2. Absolute $ Opportunity

6.3.2. Anti-inflammatory Products Segment

6.3.2.1. Y-o-Y Growth Comparison

6.3.2.2. Absolute $ Opportunity

6.3.3. Parasiticides

6.3.3.1. Y-o-Y Growth Comparison

6.3.3.2. Absolute $ Opportunity

6.3.4. Heartworm

6.3.4.1. Y-o-Y Growth Comparison

6.3.4.2. Absolute $ Opportunity

6.3.5. Behavioral Products

6.3.5.1. Y-o-Y Growth Comparison

6.3.5.2. Absolute $ Opportunity

6.3.6. Nutritional Products

6.3.6.1. Y-o-Y Growth Comparison

6.3.6.2. Absolute $ Opportunity

6.3.7. Skin Care Products

6.3.7.1. Y-o-Y Growth Comparison

6.3.7.2. Absolute $ Opportunity

6.3.8. Vaccines Product

6.3.8.1. Y-o-Y Growth Comparison

6.3.8.2. Absolute $ Opportunity

6.3.9. North America Companion Animal Drug BPS Analysis, By Product Type

6.4. Distribution Type

6.4.1. Veterinary Hospitals

6.4.1.1. Y-o-Y Growth Comparison

6.4.1.2. Absolute $ Opportunity

6.4.2. Veterinary Clinics

6.4.2.1. Y-o-Y Growth Comparison

6.4.2.2. Absolute $ Opportunity

6.4.3. Pharmacies and Drug Stores

6.4.3.1. Y-o-Y Growth Comparison

6.4.3.2. Absolute $ Opportunity

6.4.4. North America Regional Trends

6.4.5. North America Companion Animal Drug Market Drivers Impact Analysis

6.4.6. North America Companion Animal Drug Market Restraints Impact Analysis

7. Western Europe Companion Animal Drug Market Forecast 2015-2025

7.1. Introduction

7.1.1. Y-o-Y Growth Comparison

7.1.2. Absolute $ Opportunity

7.2. Western Europe Companion Animals Drug Market By Country

7.2.1. U.K.

7.2.2. France

7.2.3. Germany

7.2.4. Spain

7.2.5. Italy

7.2.6. NORDIC

7.2.7. BENELUX

7.2.8. Others

7.3. Product Type

7.3.1. Antibiotics Segment

7.3.1.1. Y-o-Y Growth Comparison

7.3.1.2. Absolute $ Opportunity

7.3.2. Anti-inflammatory Products Segment

7.3.2.1. Y-o-Y Growth Comparison

7.3.2.2. Absolute $ Opportunity

7.3.3. Parasiticides

7.3.3.1. Y-o-Y Growth Comparison

7.3.3.2. Absolute $ Opportunity

7.3.4. Heartworm

7.3.4.1. Y-o-Y Growth Comparison

7.3.4.2. Absolute $ Opportunity

7.3.5. Behavioral Products

7.3.5.1. Y-o-Y Growth Comparison

7.3.5.2. Absolute $ Opportunity

7.3.6. Nutritional Products

7.3.6.1. Y-o-Y Growth Comparison

7.3.6.2. Absolute $ Opportunity

7.3.7. Skin Care Products

7.3.7.1. Y-o-Y Growth Comparison

7.3.7.2. Absolute $ Opportunity

7.3.8. Vaccines Product

7.3.8.1. Y-o-Y Growth Comparison

7.3.8.2. Absolute $ Opportunity

7.3.9. Western Europe Companion Animals Drug Market Value Share By Product Type

7.4. Distribution Type

7.4.1. Veterinary Hospitals

7.4.1.1. Y-o-Y Growth Comparison

7.4.1.2. Absolute $ Opportunity

7.4.2. Veterinary Clinics

7.4.2.1. Y-o-Y Growth Comparison

7.4.2.2. Absolute $ Opportunity

7.4.3. Pharmacies and Drug Stores

7.4.3.1. Y-o-Y Growth Comparison

7.4.3.2. Absolute $ Opportunity

7.4.4. Western Europe Regional Trends

7.4.5. Western Europe Companion Animal Drug Market Drivers Impact Analysis

7.4.6. Western Europe Companion Animal Drug Market Restraints Impact Analysis

8. Eastern Europe Companion Animal Drug Market Forecast 2015-2025

8.1. Introduction

8.1.1. Y-o-Y Growth Comparison

8.1.2. Absolute $ Opportunity

8.2. Eastern Europe Companion Animals Drug Market By Country

8.2.1. Russia

8.2.2. Poland

8.2.3. Rest of Eastern Europe

8.3. Product Type

8.3.1. Antibiotics Segment

8.3.1.1. Y-o-Y Growth Comparison

8.3.1.2. Absolute $ Opportunity

8.3.2. Anti-inflammatory Products Segment

8.3.2.1. Y-o-Y Growth Comparison

8.3.2.2. Absolute $ Opportunity

8.3.3. Parasiticides

8.3.3.1. Y-o-Y Growth Comparison

8.3.3.2. Absolute $ Opportunity

8.3.4. Heartworm

8.3.4.1. Y-o-Y Growth Comparison

8.3.4.2. Absolute $ Opportunity

8.3.5. Behavioral Products

8.3.5.1. Y-o-Y Growth Comparison

8.3.5.2. Absolute $ Opportunity

8.3.6. Nutritional Products

8.3.6.1. Y-o-Y Growth Comparison

8.3.6.2. Absolute $ Opportunity

8.3.7. Skin Care Products

8.3.7.1. Y-o-Y Growth Comparison

8.3.7.2. Absolute $ Opportunity

8.3.8. Vaccines Product

8.3.8.1. Y-o-Y Growth Comparison

8.3.8.2. Absolute $ Opportunity

8.3.9. Eastern Europe Companion Animals Drug Market Value Share By Product Type

8.4. Distribution Type

8.4.1. Veterinary Hospitals

8.4.1.1. Y-o-Y Growth Comparison

8.4.1.2. Absolute $ Opportunity

8.4.2. Veterinary Clinics

8.4.2.1. Y-o-Y Growth Comparison

8.4.2.2. Absolute $ Opportunity

8.4.3. Pharmacies and Drug Stores

8.4.3.1. Y-o-Y Growth Comparison

8.4.3.2. Absolute $ Opportunity

8.4.4. Eastern Europe Regional Trends

8.4.5. Eastern Europe Companion Animal Drug Market Drivers Impact Analysis

8.4.6. Eastern Europe Companion Animal Drug Market Restraints Impact Analysis

9. APEJ Companion Animal Drug Market Forecast 2015-2025

9.1. Introduction

9.1.1. Y-o-Y Growth Comparison

9.1.2. Absolute $ Opportunity

9.2. APEJ Companion Animals Drug Market By Country

9.2.1. China

9.2.2. India

9.2.3. Australia and New Zealand

9.2.4. ASEAN

9.2.5. Rest of APEJ

9.2.6. Thailand

9.2.7. Taiwan

9.3. Product Type

9.3.1. Antibiotics Segment

9.3.1.1. Y-o-Y Growth Comparison

9.3.1.2. Absolute $ Opportunity

9.3.2. Anti-inflammatory Products Segment

9.3.2.1. Y-o-Y Growth Comparison

9.3.2.2. Absolute $ Opportunity

9.3.3. Parasiticides

9.3.3.1. Y-o-Y Growth Comparison

9.3.3.2. Absolute $ Opportunity

9.3.4. Heartworm

9.3.4.1. Y-o-Y Growth Comparison

9.3.4.2. Absolute $ Opportunity

9.3.5. Behavioral Products

9.3.5.1. Y-o-Y Growth Comparison

9.3.5.2. Absolute $ Opportunity

9.3.6. Nutritional Products

9.3.6.1. Y-o-Y Growth Comparison

9.3.6.2. Absolute $ Opportunity

9.3.7. Skin Care Products

9.3.7.1. Y-o-Y Growth Comparison

9.3.7.2. Absolute $ Opportunity

9.3.8. Vaccines Product

9.3.8.1. Y-o-Y Growth Comparison

9.3.8.2. Absolute $ Opportunity

9.3.9. APEJ Companion Animals Drug Market Value Share By Product Type

9.4. Distribution Type

9.4.1. Veterinary Hospitals

9.4.1.1. Y-o-Y Growth Comparison

9.4.1.2. Absolute $ Opportunity

9.4.2. Veterinary Clinics

9.4.2.1. Y-o-Y Growth Comparison

9.4.2.2. Absolute $ Opportunity

9.4.3. Pharmacies and Drug Stores

9.4.3.1. Y-o-Y Growth Comparison

9.4.3.2. Absolute $ Opportunity

9.4.4. APEJ Regional Trends

9.4.5. APEJ Companion Animal Drug Market Drivers Impact Analysis

9.4.6. APEJ Companion Animal Drug Market Restraints Impact Analysis

10. Latin America Companion Animal Drug Market Forecast 2015-2025

10.1. Introduction

10.1.1. Y-o-Y Growth Comparison

10.1.2. Absolute $ Opportunity

10.2. Latin America Companion Animals Drug Market By Country

10.2.1. Brazil

10.2.2. Mexico

10.2.3. Argentina

10.2.4. Rest of Latin America

10.3. Product Type

10.3.1. Antibiotics Segment

10.3.1.1. Y-o-Y Growth Comparison

10.3.1.2. Absolute $ Opportunity

10.3.2. Anti-inflammatory Products Segment

10.3.2.1. Y-o-Y Growth Comparison

10.3.2.2. Absolute $ Opportunity

10.3.3. Parasiticides

10.3.3.1. Y-o-Y Growth Comparison

10.3.3.2. Absolute $ Opportunity

10.3.4. Heartworm

10.3.4.1. Y-o-Y Growth Comparison

10.3.4.2. Absolute $ Opportunity

10.3.5. Behavioral Products

10.3.5.1. Y-o-Y Growth Comparison

10.3.5.2. Absolute $ Opportunity

10.3.6. Nutritional Products

10.3.6.1. Y-o-Y Growth Comparison

10.3.6.2. Absolute $ Opportunity

10.3.7. Skin Care Products

10.3.7.1. Y-o-Y Growth Comparison

10.3.7.2. Absolute $ Opportunity

10.3.8. Vaccines Product

10.3.8.1. Y-o-Y Growth Comparison

10.3.8.2. Absolute $ Opportunity

10.3.9. Latin America Companion Animals Drug Market Value Share By Product Type

10.4. Distribution Type

10.4.1. Veterinary Hospitals

10.4.1.1. Y-o-Y Growth Comparison

10.4.1.2. Absolute $ Opportunity

10.4.2. Veterinary Clinics

10.4.2.1. Y-o-Y Growth Comparison

10.4.2.2. Absolute $ Opportunity

10.4.3. Pharmacies and Drug Stores

10.4.3.1. Y-o-Y Growth Comparison

10.4.3.2. Absolute $ Opportunity

10.4.4. Latin America Regional Trends

10.4.5. Latin America Companion Animal Drug Market Drivers Impact Analysis

10.4.6. Latin America Companion Animal Drug Market Restraints Impact Analysis

11. MEA Companion Animal Drug Market Forecast 2015-2025

11.1. Introduction

11.1.1. Y-o-Y Growth Comparison

11.1.2. Absolute $ Opportunity

11.2. MEA Companion Animals Drug Market By Country

11.2.1. GCC

11.2.2. South Africa

11.2.3. Rest of MEA

11.3. Product Type

11.3.1. Antibiotics Segment

11.3.1.1. Y-o-Y Growth Comparison

11.3.1.2. Absolute $ Opportunity

11.3.2. Anti-inflammatory Products Segment

11.3.2.1. Y-o-Y Growth Comparison

11.3.2.2. Absolute $ Opportunity

11.3.3. Parasiticides

11.3.3.1. Y-o-Y Growth Comparison

11.3.3.2. Absolute $ Opportunity

11.3.4. Heartworm

11.3.4.1. Y-o-Y Growth Comparison

11.3.4.2. Absolute $ Opportunity

11.3.5. Behavioral Products

11.3.5.1. Y-o-Y Growth Comparison

11.3.5.2. Absolute $ Opportunity

11.3.6. Nutritional Products

11.3.6.1. Y-o-Y Growth Comparison

11.3.6.2. Absolute $ Opportunity

11.3.7. Skin Care Products

11.3.7.1. Y-o-Y Growth Comparison

11.3.7.2. Absolute $ Opportunity

11.3.8. Vaccines Product

11.3.8.1. Y-o-Y Growth Comparison

11.3.8.2. Absolute $ Opportunity

11.3.9. MEA Companion Animals Drug Market Value Share By Product Type

11.4. Distribution Type

11.4.1. Veterinary Hospitals

11.4.1.1. Y-o-Y Growth Comparison

11.4.1.2. Absolute $ Opportunity

11.4.2. Veterinary Clinics

11.4.2.1. Y-o-Y Growth Comparison

11.4.2.2. Absolute $ Opportunity

11.4.3. Pharmacies and Drug Stores

11.4.3.1. Y-o-Y Growth Comparison

11.4.3.2. Absolute $ Opportunity

11.4.4. MEA Regional Trends

11.4.5. MEA Companion Animal Drug Market Drivers Impact Analysis

11.4.6. MEA Companion Animal Drug Market Restraints Impact Analysis

12. Japan Companion Animal Drug Market Forecast 2015-2025

12.1. Introduction

12.2. Product Type

12.2.1. Antibiotics Segment

12.2.1.1. Y-o-Y Growth Comparison

12.2.1.2. Absolute $ Opportunity

12.2.2. Anti-inflammatory Products Segment

12.2.2.1. Y-o-Y Growth Comparison

12.2.2.2. Absolute $ Opportunity

12.2.3. Parasiticides

12.2.3.1. Y-o-Y Growth Comparison

12.2.3.2. Absolute $ Opportunity

12.2.4. Heartworm

12.2.4.1. Y-o-Y Growth Comparison

12.2.4.2. Absolute $ Opportunity

12.2.5. Behavioral Products

12.2.5.1. Y-o-Y Growth Comparison

12.2.5.2. Absolute $ Opportunity

12.2.6. Nutritional Products

12.2.6.1. Y-o-Y Growth Comparison

12.2.6.2. Absolute $ Opportunity

12.2.7. Skin Care Products

12.2.7.1. Y-o-Y Growth Comparison

12.2.7.2. Absolute $ Opportunity

12.2.8. Vaccines Product

12.2.8.1. Y-o-Y Growth Comparison

12.2.8.2. Absolute $ Opportunity

12.2.9. Japan Companion Animals Drug Market Value Share By Product Type

12.3. Distribution Type

12.3.1. Veterinary Hospitals

12.3.1.1. Y-o-Y Growth Comparison

12.3.1.2. Absolute $ Opportunity

12.3.2. Veterinary Clinics

12.3.2.1. Y-o-Y Growth Comparison

12.3.2.2. Absolute $ Opportunity

12.3.3. Pharmacies and Drug Stores

12.3.3.1. Y-o-Y Growth Comparison

12.3.3.2. Absolute $ Opportunity

12.3.4. Japan Regional Trends

12.3.5. Japan Companion Animal Drug Market Drivers Impact Analysis

12.3.5.1. Y-o-Y Growth Comparison

13. Country Tables

13.1. 13.1.UK Companion Animals Drug Market Forecast By Product Type 2014-2025

13.2. France Companion Animals Drug Market Forecast By Product Type 2014-2025

13.3. Germany Companion Animals Drug Market Forecast By Product Type 2014-2025

13.4. Brazil Companion Animals Drug Market Forecast By Product Type 2014-2025

13.5. South Africa Companion Animals Drug Market Forecast By Product Type 2014-2025

13.6. Thailand Companion Animals Drug Market Forecast By Product Type 2014-2025

13.7. Taiwan Companion Animals Drug Market Forecast By Product Type 2014-2025

14. Company Profile

14.1. Zoetis Inc.

14.2. Merck & Co., Inc.

14.3. Bayer AG

14.4. Eli Lily & Co.

14.5. Sanofi (Merial)

14.6. Ceva Santé Animale

14.7. Virbac Animal Health

14.8. Boehringer Ingelheim GmbH

15. Global Companion Animal Drug Market Forecast 2015-2025

15.1. Strategic Recommendations



【レポートのキーワード】

コンパニオンアニマル薬、ペット薬

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[コンパニオンアニマル(ペット)用薬の世界市場:産業分析・機会分析]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月07日現在 219,203 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆